Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Immunohistochemical evaluation of MYC expression in mantle cell lymphoma.

Oberley MJ, Rajguru SA, Zhang C, Kim K, Shaw GR, Grindle KM, Kahl BS, Kanugh C, Laffin J, Yang DT.

Histopathology. 2013 Oct;63(4):499-508. doi: 10.1111/his.12207. Epub 2013 Aug 8.

2.

Atypical rearrangement involving 3'-IGH@ and a breakpoint at least 400 Kb upstream of an intact MYC in a CLL patient with an apparently balanced t(8;14)(q24.1;q32) and negative MYC expression.

Amarillo I, Bui PH, Kantarci S, Rao N, Shackley BS, GarcĂ­a R, Tirado CA.

Mol Cytogenet. 2013 Feb 1;6(1):5. doi: 10.1186/1755-8166-6-5.

3.

Double-hit mantle cell lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literature.

Setoodeh R, Schwartz S, Papenhausen P, Zhang L, Sagatys EM, Moscinski LC, Shao H.

Int J Clin Exp Pathol. 2013;6(2):155-67. Epub 2013 Jan 15. Review.

4.

CD5-negative blastoid variant mantle cell lymphoma with complex CCND1/IGH and MYC aberrations.

Seok Y, Kim J, Choi JR, Kim YR, Park SJ, Kim SJ, Song J, Lee KA.

Ann Lab Med. 2012 Jan;32(1):95-8. doi: 10.3343/alm.2012.32.1.95. Epub 2011 Dec 20.

5.

An uncommon case of de novo CD10+ CD5- mantle cell lymphoma mimics follicle center B cell lymphoma.

Zapata M, Budnick SD, Bordoni R, Li S.

Int J Clin Exp Pathol. 2010 Mar 20;3(4):430-6.

Supplemental Content

Support Center